Medicament for treating thrombocytolytic purpura

A technology for platelets and purpura, applied in the biological field, can solve problems such as difficult application, difficult treatment effect, no effect, etc., and achieve the effects of convenient administration, pain relief, and remarkable therapeutic effect.

Inactive Publication Date: 2010-02-03
李忠能
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The existing commercially available traditional Chinese medicines have large individual differences in human body, some people are suitable for some people, and some people are difficult to apply, or even have no effect. Therefore, it is difficult to generally obtain ideal therapeutic effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Prepare materials according to the following ratio (kg):

[0025] Smilax tuckahoe 15, honeysuckle 20, comfrey 10, rehmannia 10, Morus alba 10, oyster 25, stinky peony 10, yellow celery 10, cicada slough 5;

[0026] Through the following method: after mixing all the above-mentioned components, use the conventional method to soak in water, extract and filter, repeat this 3 times, combine the filtrate, concentrate and dry the conventional method, and put it into the capsule shell after conventional crushing , which is a capsule for treating thrombocytopenic purpura.

Embodiment 2

[0028] Prepare materials according to the following ratio (kg):

[0029] Smilax tuckahoe 20, honeysuckle 25, comfrey 15, rehmannia glutinosa 15, Morus alba 15, oyster 30, smelly peony 15, yellow celery 15, cicada slough 10;

[0030] Through the following method: after mixing all the above-mentioned components, decocting in conventional water for 2-3 times, combining the decoctions, and subjecting to conventional sterilization, the oral liquid preparation is obtained.

Embodiment 3

[0032] Prepare materials according to the following ratio (kg):

[0033] Smilax tuckahoe 25, honeysuckle 30, comfrey 20, rehmannia glutinosa 20, Morus alba 20, oyster 35, smelly peony 20, yellow celery 20, cicada slough 15;

[0034] Through the following method: after mixing all the above-mentioned components, using conventional methods, ethanol leaching, extraction, filtration, and ethanol recovery, repeating this twice, combining the extracts, concentrating and drying by conventional methods to obtain alcohol extraction extracts, and then It is processed into tablets by adding conventional auxiliary materials in conventional dosages by conventional methods.

[0035] For showing the therapeutic effect of medicine of the present invention to thrombocytopenic purpura, the present invention is through 38 routine clinical observations, and its basic situation is: the medical history of 38 routine patients, state of an illness, age, gender and former therapeutic method are quite, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a medicament for treating thrombocytolytic purpura, which comprises the following raw materials by weight part: 15-25 parts of rhizoma smilacis glabrae, 20-30 parts of honeysuckle, 10-20 parts of radix arnebiae seu lithospermi, 10-20 parts of rehmannia root, 10-20 parts of white mulberry root-bark, 25-35 parts of oyster, 10-20 parts of clerodendrum bungei, 10-20 parts of yellow celery and 5-15 parts of cicada slough. In the invention, the natural herbal drugs capable of clearing away heat and toxic materials, activating blood and dissolving stasis, cooling and nourishingblood and stopping bleeding, removing water and eliminating swellings are selected from the medicinal treasury of China, and play roles of clearing away heat, cooling the blood, stopping the bleeding, eliminating spots, activating blood and dissolving stasis, improving the microcirculation, dredging channels, diminishing pain, and the like according to a Chinese medicine theory formula. The medicament does not contain any chemical drugs, thereby being innoxious to human bodies; and the medicament is convenient to take, can enhance the resistance and the immunity of organisms and relieve pains of patients, and has obvious curative effect.

Description

technical field [0001] The invention relates to a medicine, in particular to a traditional Chinese medicine for treating thrombocytopenic purpura, and belongs to the field of biotechnology. Background technique [0002] Thrombocytopenic purpura is a common hemorrhagic disease related to platelets. The clinical manifestations are skin bleeding (such as petechiae and ecchymosis), mucosal bleeding (such as nose, gum and oral bleeding), and internal bleeding. (such as gastrointestinal tract and urinary, reproductive system bleeding). Laboratory features include thrombocytopenia, prolonged bleeding time, poor clot retraction, and positive capillary fragility test. The disease is divided into primary and secondary two. Primary (that is, unknown cause) thrombocytopenic purpura mostly occurs in children and adolescents, mostly young women. The occurrence of this disease is related to immunity, and the spleen also plays an important role in the destruction of platelets. If the pl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61P7/04A61K35/56A61K35/64A61K35/618
Inventor 李忠能
Owner 李忠能
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap